MDA SPACE LTD (MDA.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:MDA - CA55293N1096 - Common Stock
24.9 CAD
-0.44 (-1.74%)
MDA gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 10 industry peers in the Aerospace & Defense industry. MDA has only an average score on both its financial health and profitability. MDA is not overvalued while it is showing excellent growth. This is an interesting combination.
1. Profitability
1.1 Basic Checks
MDA had positive earnings in the past year.
MDA had a positive operating cash flow in the past year.
Of the past 5 years MDA 4 years were profitable.
Each year in the past 5 years MDA had a positive operating cash flow.
1.2 Ratios
MDA has a Return On Assets of 3.15%. This is in the better half of the industry: MDA outperforms 80.00% of its industry peers.
MDA's Return On Equity of 8.24% is amongst the best of the industry. MDA outperforms 90.00% of its industry peers.
MDA's Return On Invested Capital of 5.12% is on the low side compared to the rest of the industry. MDA is outperformed by 60.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MDA is below the industry average of 8.45%.
The 3 year average ROIC (3.99%) for MDA is below the current ROIC(5.12%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 8.24% | ||
| ROIC | 5.12% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 7.40%, MDA belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
In the last couple of years the Profit Margin of MDA has grown nicely.
MDA has a worse Operating Margin (9.86%) than 60.00% of its industry peers.
MDA's Operating Margin has improved in the last couple of years.
MDA has a better Gross Margin (24.62%) than 70.00% of its industry peers.
In the last couple of years the Gross Margin of MDA has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.86% | ||
| PM (TTM) | 7.4% | ||
| GM | 24.62% |
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
2. Health
2.1 Basic Checks
MDA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
MDA has more shares outstanding than it did 1 year ago.
The debt/assets ratio for MDA has been reduced compared to a year ago.
2.2 Solvency
MDA has an Altman-Z score of 1.31. This is a bad value and indicates that MDA is not financially healthy and even has some risk of bankruptcy.
MDA has a better Altman-Z score (1.31) than 80.00% of its industry peers.
MDA has a debt to FCF ratio of 0.92. This is a very positive value and a sign of high solvency as it would only need 0.92 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.92, MDA belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
MDA has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.31, MDA is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 0.92 | ||
| Altman-Z | 1.31 |
ROIC/WACC0.58
WACC8.84%
2.3 Liquidity
A Current Ratio of 0.55 indicates that MDA may have some problems paying its short term obligations.
With a Current ratio value of 0.55, MDA is not doing good in the industry: 90.00% of the companies in the same industry are doing better.
A Quick Ratio of 0.54 indicates that MDA may have some problems paying its short term obligations.
The Quick ratio of MDA (0.54) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.54 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 98.25% over the past year.
The Earnings Per Share has been growing by 185.75% on average over the past years. This is a very strong growth
Looking at the last year, MDA shows a very strong growth in Revenue. The Revenue has grown by 57.77%.
Measured over the past years, MDA shows a very strong growth in Revenue. The Revenue has been growing by 31.32% on average per year.
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
3.2 Future
MDA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.31% yearly.
The Revenue is expected to grow by 23.78% on average over the next years. This is a very strong growth
EPS Next Y106.33%
EPS Next 2Y49.18%
EPS Next 3Y35.31%
EPS Next 5YN/A
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.78%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 22.04, the valuation of MDA can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of MDA is on the same level as its industry peers.
MDA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.46.
Based on the Price/Forward Earnings ratio of 15.98, the valuation of MDA can be described as correct.
MDA's Price/Forward Earnings ratio is in line with the industry average.
MDA is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.10, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.04 | ||
| Fwd PE | 15.98 |
4.2 Price Multiples
MDA's Enterprise Value to EBITDA ratio is in line with the industry average.
MDA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MDA is cheaper than 70.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.74 | ||
| EV/EBITDA | 12.77 |
4.3 Compensation for Growth
MDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MDA has a very decent profitability rating, which may justify a higher PE ratio.
MDA's earnings are expected to grow with 35.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.21
PEG (5Y)N/A
EPS Next 2Y49.18%
EPS Next 3Y35.31%
5. Dividend
5.1 Amount
No dividends for MDA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:MDA (12/5/2025, 7:00:00 PM)
24.9
-0.44 (-1.74%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)
Earnings (Next)
Inst Owners38.36%
Inst Owner ChangeN/A
Ins Owners1.17%
Ins Owner ChangeN/A
Market Cap3.15B
Revenue(TTM)1.48B
Net Income(TTM)109.60M
Analysts78.33
Price Target39.46 (58.47%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.07%
Min EPS beat(2)-40.3%
Max EPS beat(2)22.16%
EPS beat(4)3
Avg EPS beat(4)5.53%
Min EPS beat(4)-40.3%
Max EPS beat(4)22.16%
EPS beat(8)6
Avg EPS beat(8)21.97%
EPS beat(12)10
Avg EPS beat(12)31.49%
EPS beat(16)13
Avg EPS beat(16)66.41%
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-0.24%
Max Revenue beat(2)0.35%
Revenue beat(4)3
Avg Revenue beat(4)3.66%
Min Revenue beat(4)-0.24%
Max Revenue beat(4)7.65%
Revenue beat(8)5
Avg Revenue beat(8)2.65%
Revenue beat(12)9
Avg Revenue beat(12)2.56%
Revenue beat(16)11
Avg Revenue beat(16)1.78%
PT rev (1m)-11.19%
PT rev (3m)-24.77%
EPS NQ rev (1m)0.85%
EPS NQ rev (3m)-6%
EPS NY rev (1m)-0.69%
EPS NY rev (3m)-2.72%
Revenue NQ rev (1m)-0.89%
Revenue NQ rev (3m)-3.38%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)-0.74%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.04 | ||
| Fwd PE | 15.98 | ||
| P/S | 2.12 | ||
| P/FCF | 6.74 | ||
| P/OCF | 4.28 | ||
| P/B | 2.37 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.77 |
EPS(TTM)1.13
EY4.54%
EPS(NY)1.56
Fwd EY6.26%
FCF(TTM)3.69
FCFY14.83%
OCF(TTM)5.82
OCFY23.39%
SpS11.72
BVpS10.52
TBVpS-2.82
PEG (NY)0.21
PEG (5Y)N/A
Graham Number16.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.15% | ||
| ROE | 8.24% | ||
| ROCE | 7.1% | ||
| ROIC | 5.12% | ||
| ROICexc | 5.66% | ||
| ROICexgc | 60.4% | ||
| OM | 9.86% | ||
| PM (TTM) | 7.4% | ||
| GM | 24.62% | ||
| FCFM | 31.5% |
ROA(3y)2.27%
ROA(5y)1.16%
ROE(3y)4.65%
ROE(5y)2.1%
ROIC(3y)3.99%
ROIC(5y)N/A
ROICexc(3y)4.25%
ROICexc(5y)N/A
ROICexgc(3y)14.8%
ROICexgc(5y)N/A
ROCE(3y)5.54%
ROCE(5y)N/A
ROICexgc growth 3Y59.28%
ROICexgc growth 5YN/A
ROICexc growth 3Y71.38%
ROICexc growth 5YN/A
OM growth 3Y34.46%
OM growth 5YN/A
PM growth 3Y129.51%
PM growth 5YN/A
GM growth 3Y-9.5%
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | 0.92 | ||
| Debt/EBITDA | 1.55 | ||
| Cap/Depr | 226.87% | ||
| Cap/Sales | 18.19% | ||
| Interest Coverage | 9.36 | ||
| Cash Conversion | 277.94% | ||
| Profit Quality | 425.55% | ||
| Current Ratio | 0.55 | ||
| Quick Ratio | 0.54 | ||
| Altman-Z | 1.31 |
F-Score6
WACC8.84%
ROIC/WACC0.58
Cap/Depr(3y)234.8%
Cap/Depr(5y)169.15%
Cap/Sales(3y)23.53%
Cap/Sales(5y)18.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.25%
EPS 3Y185.75%
EPS 5YN/A
EPS Q2Q%-16.67%
EPS Next Y106.33%
EPS Next 2Y49.18%
EPS Next 3Y35.31%
EPS Next 5YN/A
Revenue 1Y (TTM)57.77%
Revenue growth 3Y31.32%
Revenue growth 5YN/A
Sales Q2Q%45.11%
Revenue Next Year52.26%
Revenue Next 2Y30.25%
Revenue Next 3Y23.78%
Revenue Next 5YN/A
EBIT growth 1Y64.41%
EBIT growth 3Y76.57%
EBIT growth 5YN/A
EBIT Next Year182.28%
EBIT Next 3Y51.82%
EBIT Next 5YN/A
FCF growth 1Y631.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y674.42%
OCF growth 3Y124.48%
OCF growth 5YN/A
MDA SPACE LTD / MDA.CA FAQ
What is the fundamental rating for MDA stock?
ChartMill assigns a fundamental rating of 6 / 10 to MDA.CA.
What is the valuation status for MDA stock?
ChartMill assigns a valuation rating of 6 / 10 to MDA SPACE LTD (MDA.CA). This can be considered as Fairly Valued.
What is the profitability of MDA stock?
MDA SPACE LTD (MDA.CA) has a profitability rating of 6 / 10.
What is the valuation of MDA SPACE LTD based on its PE and PB ratios?
The Price/Earnings (PE) ratio for MDA SPACE LTD (MDA.CA) is 22.04 and the Price/Book (PB) ratio is 2.37.